Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Other: No intervention
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Invitae Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT06043921
- Locations
- ๐ฏ๐ต
National Cancer Center Hospital East, Kashiwa, Japan
PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients
Completed
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: Invitae multi-cancer gene panel
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- Invitae Corporation
- Target Recruit Count
- 1000
- Registration Number
- NCT05447637
- Locations
- ๐บ๐ธ
Colorado Urology, Lakewood, Colorado, United States
๐บ๐ธAssociated Urological Specialists, Chicago Ridge, Illinois, United States
๐บ๐ธAdvanced Urology Institute, Saint Petersburg, Florida, United States
Universal Germline Testing in the Community
Recruiting
- Conditions
- Solid TumorSolid Tumor, AdultCancer
- Interventions
- Diagnostic Test: Invitae's 84 gene multi-cancer panel.
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Invitae Corporation
- Target Recruit Count
- 1000
- Registration Number
- NCT05416710
- Locations
- ๐บ๐ธ
Carolina Blood and Cancer Care Associates, PA', Rock Hill, South Carolina, United States
ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing
Terminated
- Conditions
- Pancreatic CancerResectable Pancreatic CancerPancreatic Adenocarcinoma
- Interventions
- Diagnostic Test: Germline genetic testing
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Invitae Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT05380557
- Locations
- ๐บ๐ธ
Invitae SF, San Francisco, California, United States
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Active, not recruiting
- Conditions
- Non Small Cell Lung CancerCancerSolid TumorColorectal CancerBladder Cancer
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Invitae Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT05219734
- Locations
- ๐บ๐ธ
Columbus Regional Health, Columbus, Indiana, United States
๐บ๐ธOnslow Radiation, Jacksonville, North Carolina, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath